DOCSLIB.ORG

Lung Transplantation in the Third Millennium Third the in Lung Transplantation in the Third Millennium

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Lung Transplantation in the Third Millennium Third the in Lung Transplantation in the Third Millennium AME Medical Book 1A025 1A025 Lung Transplantation in the Third Millennium Transplantation Lung in the Third Millennium Editors: Dirk Van Raemdonck Federico Venuta www.amegroups.com Editors: Federico Venuta Raemdonck Dirk Van Lung Transplantation in the Third Millennium Editors: Dirk Van Raemdonck Federico Venuta AME Publishing Company Room C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong Information on this title: www.amegroups.com For more information, contact [email protected] Copyright © AME Publishing Company. All rights reserved. This publication is in copyright. Subject to statutory exception and to the provisions of relevant collective licensing agreements, no reproduction of any part may take place without the written permission of AME Publishing Company. First published in 2018 Printed in China by AME Publishing Company Editors: Dirk Van Raemdonck, Federico Venuta Lung Transplantation in the Third Millennium (Hard Cover) ISBN: 978-988-77840-4-3 AME Publishing Company, Hong Kong AME Publishing Company has no responsibility for the persistence or accuracy of URLs for external or third-party internet websites referred to in this publication, and does not guarantee that any content on such websites is, or will remain, accurate or appropriate. The advice and opinions expressed in this book are solely those of the authors and do not necessarily represent the views or practices of the publisher. No representation is made by the publisher about the suitability of the information contained in this book, and there is no consent, endorsement or recommendation provided by the publisher, express or implied, with regard to its contents. I LUNG TRANSPLANTATION IN THE THIRD MILLENNIUM (FIRST EDITION) EDITORS Greg L. Calligaro Division of Pulmonology, Department of Medicine, Groote Dirk Van Raemdonck Schuur Hospital, Cape Town, South Africa Department of Thoracic Surgery, University Hospitals Leuven and Department of Clinical and Experimental Edward Cantu Medicine, KU Leuven University, Leuven, Belgium Division of Cardiovascular Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, USA Federico Venuta Department of Thoracic Surgery, Policlinico Umberto I Andrew Courtwright and University of Rome La Sapienza, Rome, Italy Division of Pulmonary and Critical Care Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA CONTRIBUTORS Xavier-Benoit D’Journo Michaela R. Anderson Department of Thoracic Surgery, Disease of the Division of Pulmonary, Allergy and Critical Care Medicine, Oesophagus and Lung Transplantations, Hôpital Nord, Department of Medicine, Columbia University Medical Aix- Marseille University, Marseille, France Center, New York, USA Hiroshi Date Selim M. Arcasoy The Department of Thoracic Surgery, Kyoto University Division of Pulmonary, Allergy and Critical Care Medicine, Graduate School of Medicine, Kyoto, Japan Department of Medicine, Columbia University Medical Center, New York, USA Stephanie Dizier Department of Thoracic Surgery, Disease of the Christian Benden Oesophagus and Lung Transplantations, Hôpital Nord, Division of Pulmonology, University Hospital Zurich, Aix- Marseille University, Marseille, France Zurich, Switzerland Christophe Doddoli Luke J. Benvenuto Department of Thoracic Surgery, Disease of the Division of Pulmonary, Allergy and Critical Care Medicine, Oesophagus and Lung Transplantations, Hôpital Nord, Department of Medicine, Columbia University Medical Aix- Marseille University, Marseille, France Center, New York, USA Lieven Dupont Mark Benzimra Department of Respiratory Diseases, Lung Transplantation Heart and Lung Transplant Unit, St Vincent’s Hospital, Unit, University Hospital Gasthuisberg KU Leuven, Sydney, Australia Leuven, Belgium Geoffrey Brioude Department of Thoracic Surgery, Disease of the Oesophagus and Lung Transplantations, Hôpital Nord, Aix- Marseille University, Marseille, France © AME Publishing Company. All rights reserved. www.amegroups.com II Elie Fadel Fabio Ius Service de Chirurgie Thoracique, Vasculaire et Department of Cardiothoracic, Transplant and Vascular Transplantation Cardio-pulmonaire, H pital Marie- Surgery, Hannover Medical School, Hannover, Germany Lannelongue, Le Plessis-Robinson, France; Universit Paris-Sud, Facult de M decine, Universit Paris-Saclay, Le Jérôme Le Pavec Kremlin Bic tre, France; UMR_S 999, Universit Paris- Service de Chirurgie Thoracique, Vasculaire et Sud, INSERM, H pital Marie Lannelongue, Le Plessis- Transplantation Cardio-pulmonaire, H pital Marie- Robinson, France Lannelongue, Le Plessis-Robinson, France; Universit Paris-Sud, Facult de M decine, Universit Paris-Saclay, Le Pierre-Emmanuel Falcoz Kremlin Bic tre, France; UMR_S 999, Universit Paris- Lung Transplantation Group, University Hospital Sud, INSERM, H pital Marie Lannelongue, Le Plessis- Strasbourg, Strasbourg, France; INSERM (French institute Robinson, France for health and medical research) 1260 Regenerative Nanomedecine, Translational Medicine Federation of Marc Leone Strasbourg, University of Strasbourg, Strasbourg, France Department of Anesthesiology, Hôpital Nord, Aix- Marseille University, Marseille, France Andrew John Fisher Institute of Transplantation, Freeman Hospital, Newcastle Gabriel Loor Upon Tyne, UK; Institute of Cellular Medicine, Faculty of Division of Cardiothoracic Transplantation and Circulatory Medical Sciences, Newcastle University, Newcastle Upon Support, Department of Surgery, Baylor College of Tyne, UK Medicine, Houston, TX, USA Allan R. Glanville Herve Mal Heart and Lung Transplant Unit, St Vincent’s Hospital, INSERM U1152, Université Paris Diderot, Paris, France Sydney, Australia Gilbert Massard Jens Gottlieb Lung Transplantation Group, University Hospital Department of Respiratory Medicine, Hannover Medical Strasbourg, Strasbourg, France; INSERM (French institute School, Hannover, Germany; Biomedical Research in End- for health and medical research) 1260 Regenerative stage and Obstructive Disease (BREATH), German Centre Nanomedecine, Translational Medicine Federation of for Lung Research (DZL), Hannover, Germany Strasbourg, University of Strasbourg, Strasbourg, France Lucile Gust Bryan F. Meyers Department of Thoracic Surgery, Disease of the Division of Cardiothoracic Surgery, Washington University Oesophagus and Lung Transplantations, Hôpital Nord, School of Medicine, St. Louis, MO, USA Aix- Marseille University, Marseille, France Letizia Corinna Morlacchi Sébastien Hascoët Internal Medicine Department, Respiratory Unit and Cystic Universit Paris-Sud, Facult de M decine, Universit Paris- Fibrosis Adult Centre, Ca’ Granda Foundation IRCCS Saclay, Le Kremlin Bic tre, France; Service de Cardiop Ospedale Maggiore Policlinico, Milano, Italy; Department diatrie, Centre de R f rence des Malformations Cardiaques of Pathophysiology and Transplantation, Università degli Cong nitales Complexes M3C, H pital Marie-Lannelongue, Studi di Milano, Milano, Italy Le Plessis-Robinson, France Morvern Isabel Morrison Ilhan Inci Institute of Transplantation, Freeman Hospital, Newcastle Department of Thoracic Surgery, University Hospital, Upon Tyne, UK; Institute of Cellular Medicine, Faculty of University of Zurich, Zurich, Switzerland Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK © AME Publishing Company. All rights reserved. www.amegroups.com III Arne Neyrinck Melanie P. Subramanian Department of Amesthesiology, Lung Transplantation Unit, Division of Cardiothoracic Surgery, Washington University University Hospital Gasthuisberg KU Leuven, Leuven, School of Medicine, St. Louis, MO, USA Belgium Paolo Tarsia Mario Nosotti Internal Medicine Department, Respiratory Unit and Cystic Thoracic Surgery and Lung Transplantation Unit, Milano, Fibrosis Adult Centre, Ca’ Granda Foundation IRCCS Italy Ospedale Maggiore Policlinico, Milano, Italy; Department of Pathophysiology and Transplantation, Università degli Anne Olland Studi di Milano, Milano, Italy Lung Transplantation Group, University Hospital Strasbourg, Strasbourg, France; INSERM (French Gabriel Thabut institute for health and medical research) 1260 Service de pneumologie et transplantation pulmonaire, Regenerative Nanomedecine, Translational Medicine Hôpital Bichat, Paris, France Federation of Strasbourg, University of Strasbourg, Strasbourg, France Pascal-Alexandre Thomas Department of Thoracic Surgery, Disease of the Amit Parulekar Oesophagus and Lung Transplantations, Hôpital Nord, Section of Pulmonary, Critical Care and Sleep Medicine, Aix- Marseille University, Marseille, France CHI St. Luke’s Health-Baylor St. Luke’s Medical Center, Houston, TX, USA Delphine Trousse Department of Thoracic Surgery, Disease of the Thomas Leonard Pither Oesophagus and Lung Transplantations, Hôpital Nord, Institute of Transplantation, Freeman Hospital, Newcastle Aix- Marseille University, Marseille, France Upon Tyne, UK; Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Igor Tudorache Tyne, UK Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany Filip Rega Department of Cardiac Surgery, University Hospitals Anke Van Herck Leuven, Leuven, Belgium; Department of Cardiovascular Department of Respiratory Diseases, University Hospitals Sciences, KU Leuven University, Leuven, Belgium Leuven, Leuven, Belgium; Department of Chronic Diseases, Metabolism & Ageing (CHROMETA), Division Steffen Rex of Respiratory Diseases, KU Leuven, Leuven, Belgium Department of Cardiovascular
Load more

Recommended publications
  • Ethical Implications of Multi-Organ Transplants OPTN/UNOS Ethics Committee
    Public Comment Proposal Ethical Implications of Multi-Organ Transplants OPTN/UNOS Ethics Committee Prepared by: Abigail Fox, MPA UNOS Policy & Community Relations Department Contents Executive Summary 1 Is the sponsoring Committee requesting specific feedback or input about the resource? 1 What problem will this resource address? 1 Why should you support this resource? 1 How was this resource developed? 1 How well does this resource address the problem statement? 3 Which populations are impacted by this resource? 3 How does this resource impact the OPTN Strategic Plan? 4 How will the OPTN implement this resource? 5 How will members implement this resource? 5 Will this resource require members to submit additional data? 5 How will members be evaluated for compliance with this resource? 5 White Paper 6 OPTN/UNOS Public Comment Proposal Ethical Implications of Multi-Organ Transplants Affected Policies: N/A Sponsoring Committee: Ethics Committee Public Comment Period: January 22, 2019 – March 22, 2019 Executive Summary The allocation policies for multi-organ transplant (MOT) have the potential to create inequity in the organ distribution process, either in the rate of transplantation or in the time to transplantation. Such potential inconsistencies may affect the patients who are awaiting MOT as well as those who are awaiting single organ transplantation (SOT) because both groups depend upon available organs from the same limited donor pool. Prioritization of MOT candidates and the allocation rules for each combination have not been standardized across the different organs. As a result, the current allocation system has generated confusion in the transplant community about the rationale for differences in MOT allocation plans between different organ combinations.
    [Show full text]
  • Performance Changes Following the Revision of Organ Allocation System of Lung Transplant
    J Korean Med Sci. 2021 Mar 29;36(12):e79 https://doi.org/10.3346/jkms.2021.36.e79 eISSN 1598-6357·pISSN 1011-8934 Original Article Performance Changes Following the Cell Therapy & Organ Transplantation Revision of Organ Allocation System of Lung Transplant: Analysis of Korean Network for Organ Sharing Data Hye Ju Yeo ,1,2 Do Hyung Kim ,3 Yun Seong Kim ,1 Doosoo Jeon ,1 and Woo Hyun Cho 1,2 1Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea Received: Aug 4, 2020 2Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Accepted: Jan 13, 2021 Yangsan Hospital, Yangsan, Korea 3Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Yangsan, Address for Correspondence: Korea Woo Hyun Cho, MD Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine and Research Institute for ABSTRACT Convergence of Biomedical Science and Technology, Pusan National University Background: There is currently a lack of data on the impact of the recent revision of the Yangsan Hospital, 20 Geumo-ro, Mulgeum- eup, Yangsan 50612, Republic of Korea. domestic lung allocation system on transplant performance. E-mail: [email protected] Methods: We conducted a retrospective analysis of transplant candidates and transplant patients registered in Korean Network for Organ Sharing between July 2015 and July 2019. Study © 2021 The Korean Academy of Medical periods were classified according to the introduction of the revised lung allocation system as Sciences. This is an Open Access article distributed follows: period 1 from July 2015 to June 2017 and period 2 from August 2017 to July 2019.
    [Show full text]
  • Vascularized Composite Allografts (Lc Cendales, Section Editor)
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Springer - Publisher Connector Curr Transpl Rep (2014) 1:173–182 DOI 10.1007/s40472-014-0025-6 VASCULARIZED COMPOSITE ALLOGRAFTS (LC CENDALES, SECTION EDITOR) Vascularized Composite Allografts: Procurement, Allocation, and Implementation Axel Rahmel Published online: 3 July 2014 # The Author(s) 2014. This article is published with open access at Springerlink.com Abstract Vascularized composite allotransplantation is a allotransplantation. In 2005, the first face transplantation was continuously evolving area of modern transplant medicine. performed in Lyon [5]; since then the number of face trans- Recently, vascularized composite allografts (VCAs) have plants has increased [6]. This special category of transplants is been formally classified as ‘organs’.Inthisreview,keyas- localized at the border between tissue and organ transplanta- pects of VCA procurement are discussed, with a special focus tion. The term composite tissue allotransplantation (CTA) on interaction with the procurement of classical solid organs. used in the past reflects that it was often considered as a In addition, options for a matching and allocation system that special type of tissue transplantation [7]. Several reports ensures VCA donor organs are allocated to the best-suited looking in-depth at limb and face transplantation made it clear recipients are looked at. Finally, the different steps needed to that vascularized composite allotransplantation is in central promote VCA transplantation in society in general and in the aspects more similar to organ than to tissue transplantation medical community in particular are highlighted. [7–12]. After careful evaluation involving the transplant com- munity and the general public, the United States Department of Health and Human Services recently published its decision Keywords Transplantation .
    [Show full text]
  • Pulmonary Transplantation Council
    INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION (ISHLT) LUNG TRANSPLANTATION CORE COMPETENCY CURRICULUM (ISHLT LTX CCC) SECOND EDITION June 2017 THE EDUCATIONAL WORKFORCE OF THE ISHLT PULMONARY TRANSPLANTATION COUNCIL L. LEARD, G. DELLEGREN, and D. DILLING Acknowledgements to First Edition Authors: T. ASTOR, G. BERRY, K. CHAN, D. MASON, D. LEVINE, C. WIGFIELD CONTACT: EMAIL: [email protected] TEL: 708-327-2488 FAX: 708-327-2382 1 (V 2.0 June 15, 2017) ISHLT PULMONARY TRANSPLANTATION COUNCIL EDUCATION WORKFORCE CHAIR LORRIANA LEARD, MD UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER SAN FRANCISCO, CALIFORNIA, USA [email protected] CO-CHAIRS GORAN DELLEGREN, MD, PHD SAHLGRENSKA UNIVERSITY HOSPITAL GOTEBORG, SWEDEN [email protected] DANIEL DILLING, MD LOYOLA UNIVERSITY MEDICAL CENTER MAYWOOD, ILLINOIS, USA [email protected] ACKNOWLEDGEMENT OF PRIOR CURRICULTUM CONTENT AUTHORS: KEVIN M. CHAN, MD UNIVERSITY OF MICHIGAN HEALTH SYSTEM 1500 EAST MEDICAL CENTER 3916 TAUBMAN CENTER, BOX 0360 ANN ARBOR, MI 48109 734-936-5047 734-936-7048 (FAX) [email protected] DEBORAH J. LEVINE, MD UT HEALTH CENTER @ SAN ANTONIO 7703 FLOYD CURL DR. DEPT. OF SURGERY, MC 7841 SAN ANTONIO, TX 78229 210-567-5616 210-567-2877 (FAX) [email protected] DAVID P. MASON, MD CLEVELAND CLINIC FOUNDATION THORACIC & CV SURGERY, J4-1 9500 EUCLID AVE. CLEVELAND, OH 44195 216-444-4053 216-445-6876 (FAX) 2 [email protected] GERRY J. BERRY MD STANFORD UNIVERSITY MEDICAL CENTER DEPT. ANATOMIC PATHOLOGY 300 PASTEUR DRIVE SUIT H 2110 STANFORD, CA 94305 650- 723- 7211 650-725-7409 (FAX) [email protected] TODD L. ASTOR, MD PULMONARY AND CRITICAL CARE UNIT MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET, BULFINCH 148 BOSTON, MA 02114 617-623-9704 [email protected] 3 ISHLT LTX CCC: LIST OF CONTENTS I.
    [Show full text]
  • A Guide to Calculating the Lung Allocation Score
    A Guide to Calculating the Lung Allocation Score U.S. lung allocation policy prioritizes lung transplant candidates for lung offers by assigning them a lung allocation score. What is the Lung Allocation Score? The lung allocation score (LAS) is used to prioritize waiting list candidates based on a combination of waitlist urgency and post-transplant survival. In this context, waitlist urgency is defined as what is expected to happen to a candidate, given his or her characteristics, in the next year if he or she doesn’t receive a transplant. Post-transplant survival is defined as what is expected to happen to a candidate, given his or her characteristics, in the first year after a transplant if he or she does receive the transplant. What is involved in the LAS calculation? The LAS involves the following steps: 1. Calculate the waiting list survival probability during the next year 2. Calculate the waitlist urgency measure 3. Calculate the post-transplant survival probability during the first post-transplant year 4. Calculate the post-transplant survival measure 5. Calculate the raw allocation score 6. Normalize the raw allocation score to obtain the LAS. A detailed explanation for each of the steps follows. How is the LAS actually calculated? We’ve computed the LAS for a hypothetical candidate to help you understand the process. The following description of the calculation of the LAS in this document assumes that all characteristics are known. With the exception of a few characteristics (e.g., age and diagnosis), the LAS can also be computed when characteristics are missing.
    [Show full text]
  • Historical Perspectives of Lung Transplantation: Connecting the Dots
    4531 Review Article Historical perspectives of lung transplantation: connecting the dots Tanmay S. Panchabhai1, Udit Chaddha2, Kenneth R. McCurry3, Ross M. Bremner1, Atul C. Mehta4 1Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, USA; 2Department of Pulmonary and Critical Care Medicine, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA; 3Department of Cardiothoracic Surgery, Sydell and Arnold Miller Family Heart and Vascular Institute; 4Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH, USA Contributions: (I) Conception and design: TS Panchabhai, AC Mehta; (II) Administrative support: TS Panchabhai, RM Bremner, AC Mehta; (III) Provision of study materials or patients: TS Panchabhai, U Chaddha; (IV) Collection and assembly of data: TS Panchabhai, U Chaddha, AC Mehta; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Atul C. Mehta, MD, FCCP. Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA; Staff Physician, Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH, USA. Email: [email protected]. Abstract: Lung transplantation is now a treatment option for many patients with end-stage lung disease. Now 55 years since the first human lung transplant, this is a good time to reflect upon the history of lung transplantation, to recognize major milestones in the field, and to learn from others’ unsuccessful transplant experiences. James Hardy was instrumental in developing experimental thoracic transplantation, performing the first human lung transplant in 1963. George Magovern and Adolph Yates carried out the second human lung transplant a few days later.
    [Show full text]
  • HARBIN. NOVEMBER 2017. Sergio
    POWER OVER LIFE AND DEATH Natalie Köhle ARBIN. NOVEMBER 2017. Sergio NESS is NOT in the BRAIN, which seeks HCanavero and Ren Xiaoping 任晓 to prove the existence of an eternal 平 announced that the world’s first hu- soul on the basis of near death experi- man head transplant was ‘imminent’. ence, as well as two guides on seducing They had just completed an eight- women. He also drops flippant refer- een-hour rehearsal on two human ca- ences to Stalin or the Nazi doctor Josef davers, and now claimed to be ready Mengele. for the real deal: the transplant of a human head from a living person with a degenerative disease onto a healthy, but brain-dead, donor body.1 Ren — a US-educated Chinese orthopaedic surgeon, was part of the team that performed the first hand transplant in Louisville in 1999. Canavero, an Italian, and former neu- rosurgeon at the university of Turin, is the more controversial, maverick per- sona of the team. In addition to many respected scientific publications, he Frankenstein’s Monster from The Bride of Frankenstein (1935) published Immortal: Why CONSCIOUS- Source: Commons Wikimedia 276 tor function and sensation. It would 277 also depend on the unproven capacity of the human brain to adjust to — and gain control over — a new body and a new nervous system without suffering debilitating pain or going mad.2 So far, Ren and Canavero have Sergio Canavero transplanted the heads of numerous Source: 诗凯 陆, Flickr lab mice and one monkey, and they Ren and Canavero see the head have also severed and subsequently Power over Life and Death Natalie Köhle transplant, formally known as cepha- mended the spinal cords of several POWER losomatic anastomosis, as the logical dogs.
    [Show full text]
  • Lung Transplantation Adriaan Myburgh
    Lung Transplantation Adriaan Myburgh ! UNIVERSITY OF CAPE TOWN ! Department of Anaesthesia and Perioperative Medicine ! ! ! ! ! ! ! Disclosure Jenna Lowe “ Get me to 21” • 4065 Donors Phalo - URE History • 1947: Vladimir Demikhov performs first successful animal lung transplantation • 1963: James Hardy performs first human lung transplantation in Jackson Mississippi 3 December 1967: First Human heart transplant Denise Darvall to Louis Washkansy • 1986: Joel Cooper performs first successful human double lung transplantation • 2001: Stig Steen performed first successful Non Heart Beating lung transplantation • 2007: Stig Steen performs first ex-vivo reconditioning human lung transplantation Recipients Relative contraindications to lung transplantation • Age > 65 years • Critical or unstable condition (eg, shock, ECMO) • Severely limited functional status • Colonization with highly resistant bacteria, fungi or mycobacteria • Severe obesity (BMI > 30 kg/m2) • Severe osteoporosis • Mechanical ventilation • Other significant medical conditions Orens JB et al. J Heart Lung Transplant 2006; 25: 745-55 Contraindications ? Relative contraindications to lung transplantation • Age > 65 years • Critical or unstable condition (eg, shock, ECMO) • Severely limited functional status • Colonization with highly resistant bacteria, fungi or mycobacteria • Severe obesity (BMI > 30 kg/m2) • Severe osteoporosis • Mechanical ventilation • Other significant medical conditions ECMO Bridge-to-transplant Lung assist device (Novalung®) ECMO Strueber M. Curr Opin Organ
    [Show full text]
  • The Morality of Head Transplant: Frankenstein’S Allegory
    5 THE MORALITY OF HEAD TRANSPLANT: FRANKENSTEIN’S ALLEGORY Aníbal Monasterio Astobiza1 Abstract: In 1970 Robert J. White (1926-2010) tried to transplant the head of a Rhesus monkey into another monkey’s body. He was in- spired by the work of a Russian scientist, Vladimir Demikhov (1916- 1998), who had conducted similar experiments in dogs. Both Demikhov and White have been successful pioneers of organ transplantation, but their scientific attempts to transplant heads of mammals are often remem- bered as infamous. Both scientists encountered important difficulties in such experiments, including their incapacity to link the spinal cord, which ended up by creating quadriplegic animals. In 2013, neurosurgeon Sergio Canavero claimed his capacity and plan to carry out the first human head 1 I am grateful to the Basque Government sponsorship for carrying out a posdoc- toral research fellowship at the Uehiro Centre for Practical Ethics of the University of Oxford, and to the latter institution for its warm welcome. Also, I would like to thank David Rodríguez-Arias for his invaluable comments and suggestions for the improvement of this paper. As usual, any error is solely the author’s responsibility. This work was carried out within the framework of the following research projects: KONTUZ!: “Responsabilidad causal de la comisión por omisión: Una dilucidadión ético-jurídica de los problemas de la acción indebida” (MINECO FFI2014-53926-R); “La constitución del sujeto en la interacción social: identidad, normas y sentido de la acción desde la perspectiva de la filosofía de la acción, la epistemología y la filosofía experimental” (FFI2015-67569-C2-2-P), and “Artificial Intelligence and Biotechnol- ogy of Moral Enhancement Ethical Aspects” (FFI2016-79000-P).
    [Show full text]
  • Effect of the Lung Allocation Score on Lung Transplantation in the United States
    http://www.jhltonline.org Effect of the lung allocation score on lung transplantation in the United States Thomas M. Egan, MD, MSc,a,1 and Leah B. Edwards, PhDb From the aDivision of Cardiothoracic Surgery, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and the bUnited Network for Organ Sharing, Richmond, Virginia. KEYWORDS: BACKGROUND: On May 4, 2005, the system for allocation of deceased donor lungs for transplant in the lung transplant; United States changed from allocation based on waiting time to allocation based on the lung allocation lung allocation score; score (LAS). We sought to determine the effect of the LAS on lung transplantation in the United States. organ allocation; METHODS: Organ Procurement and Transplantation Network data on listed and transplanted patients were transplant benefit; analyzed for 5 calendar years before implementation of the LAS (2000–2004), and compared with data transplant urgency from 6 calendar years after implementation (2006–2011). Counts were compared between eras using the Wilcoxon rank sum test. The rates of transplant increase within each era were compared using an F-test. Survival rates computed using the Kaplan-Meier method were compared using the log-rank test. RESULTS: After introduction of the LAS, waitlist deaths decreased significantly, from 500/year to 300/ year; the number of lung transplants increased, with double the annual increase in rate of lung transplants, despite no increase in donors; the distribution of recipient diagnoses changed dramatically, with significantly more patients with fibrotic lung disease receiving transplants; age of recipients increased significantly; and 1-year survival had a small but significant increase.
    [Show full text]
  • Lung Transplantation Core Competency Curriculum
    INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION (ISHLT) LUNG TRANSPLANTATION CORE COMPETENCY CURRICULUM (ISHLT LTX CCC) FIRST EDITION THE EDUCATIONAL WORKFORCE OF THE ISHLT PULMONARY TRANSPLANTATION COUNCIL T. ASTOR, G. BERRY, K. CHAN, D. MASON, D. LEVINE, C. WIGFIELD CONTACT: EMAIL: [email protected] TEL: 708-327-2488 FAX: 708-327-2382 (V 4.0 AUGUST 2010) 1 ISHLT PULMONARY TRANSPLANTATION COUNCIL EDUCATION WORKFORCE WORKFORCE LEADER CHRISTOPHER H. WIGFIELD, MD, FRCS LOYOLA UNIVERSITY MEDICAL CENTER DEPT OF THORACIC & CARDIOVASCULAR SURGERY 2160 S. 1ST AVE, BLDG 110 MAYWOOD, IL 60153 708-327-2488 708-327-2382 (FAX) [email protected] WORKFORCE MEMBERS KEVIN M. CHAN, MD UNIVERSITY OF MICHIGAN HEALTH SYSTEM 1500 EAST MEDICAL CENTER 3916 TAUBMAN CENTER, BOX 0360 ANN ARBOR, MI 48109 734-936-5047 734-936-7048 (FAX) [email protected] DEBORAH J. LEVINE, MD UT HEALTH CENTER @ SAN ANTONIO 7703 FLOYD CURL DR. DEPT. OF SURGERY, MC 7841 SAN ANTONIO, TX 78229 210-567-5616 210-567-2877 (FAX) [email protected] DAVID P. MASON, MD CLEVELAND CLINIC FOUNDATION THORACIC & CV SURGERY, J4-1 9500 EUCLID AVE. CLEVELAND, OH 44195 216-444-4053 216-445-6876 (FAX) [email protected] GERRY J. BERRY MD STANFORD UNIVERSITY MEDICAL CENTER DEPT. ANATOMIC PATHOLOGY 300 PASTEUR DRIVE SUIT H 2110 STANFORD, CA 94305 650- 723- 7211 650-725-7409 (FAX) [email protected] TODD L. ASTOR, MD PULMONARY AND CRITICAL CARE UNIT MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET, BULFINCH 148 BOSTON, MA 02114 617-623-9704 [email protected] 2 ISHLT LTX CCC: LIST OF CONTENTS I. INTRODUCTION TO TRANSPLANTATION: BACKGROUND AND ISHLT REGISTRY P 7 (C H WIGFIELD MD) LEARNING OBJECTIVES 1.
    [Show full text]
  • A Contemporary Review of Adult Lung Transplantation and the Portuguese Lung Transplant Program Revised
    MESTRADO INTEGRADO MEDICINA A Contemporary Review of Adult Lung Transplantation and the Portuguese Lung Transplant Program Revised Maria Inês dos Reis Rodrigues M 2019 A Contemporary Review of Adult Lung Transplantation and the Portuguese Lung Transplant Program revised Maria Inês dos Reis Magalhães Rodrigues I [email protected] Mestrado Integrado em Medicina Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto Orientador: Professor Doutor Humberto José da Silva Machado Professor Associado Convidado do Instituto de Ciências Biomédicas Abel Salazar Assistente Hospitalar Graduado Sénior de Anestesiologia do Centro Hospitalar do Porto Diretor do Serviço de Anestesiologia do Centro Hospitalar do Porto Adjunto da Direção Clínica do Centro Hospitalar do Porto Maio 2019 24 de maio de 2019 Agradecimentos Ao Professor Doutor Humberto Machado pela orientação, disponibilidade, interesse e apoio que sempre demonstrou, indispensáveis para a realização do presente trabalho. Aos meus pais e irmã, pelos valores transmitidos e por toda a ajuda e companheirismo ao longo do meu percurso de vida. i Resumo Introdução: O transplante pulmonar é atualmente uma opção terapêutica para doentes com doença pulmonar terminal. Nos últimos 30 anos verificou-se um constante crescimento na área da transplantação pulmonar e, com o desenvolvimento de novos fármacos imunossupressores e o aperfeiçoamento de técnicas cirúrgicas e de conservação de órgãos, houve um aumento da sobrevivência e da qualidade de vida dos doentes transplantados. Em Portugal, o programa de transplantação pulmonar teve início em 2001 no Hospital Santa Marta, Centro Hospitalar de Lisboa Central. Apesar de ser o único centro de transplantação pulmonar do país, um número crescente de transplantes pulmonares tem vindo a ser realizado, passando de 8 transplantes realizados em 2009 para 34 transplantes realizados em 2017.
    [Show full text]